Literature DB >> 21910160

SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.

Esther A Peterson1, Laura Stanbery, Christina Li, Hande Kocak, Olga Makarova, Elizabeth M Petty.   

Abstract

Septins are highly conserved cytoskeletal GTP-binding proteins implicated in numerous cellular processes from apoptosis to vesicle trafficking. Septins have been associated with leukemia and solid tumor malignancies, including breast, ovarian, and prostate. We previously reported that high SEPT9_i1 expression in human mammary epithelial cell lines (HMECs) led to malignant cellular phenotypes such as increased cell proliferation, invasiveness, motility, and genomic instability. Our goal here was to better understand how SEPT9_i1 expression might contribute to genomic instability and malignant progression. First, we confirmed that even transient expression of SEPT9_i1 was sufficient to increase aneuploidy in HMECs. We then analyzed SEPT9_i1 by immunoprecipitation and immunofluorescence studies and found that SEPT9_i1 interacts with both α and γ tubulin. SEPT9_i1 expressing cells demonstrated dramatic chromosome segregation defects, centrosome amplification and cytokinesis defects, suggesting two possible molecular mechanisms contributing to the development of genomic instability. This suggests that SEPT9_i1 may promote genomic instability through both cytokinesis and mitotic spindle defects which lead to chromosome missegregation.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910160      PMCID: PMC3172617          DOI: 10.1002/gcc.20916

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

Review 1.  A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy.

Authors:  Ignacio Pérez de Castro; Guillermo de Cárcer; Marcos Malumbres
Journal:  Carcinogenesis       Date:  2007-01-27       Impact factor: 4.944

2.  Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules.

Authors:  Koh-Ichi Nagata; Aie Kawajiri; Seiya Matsui; Mihoko Takagishi; Takashi Shiromizu; Noriko Saitoh; Ichiro Izawa; Tohru Kiyono; Tomohiko J Itoh; Hirokazu Hotani; Masaki Inagaki
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

3.  MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.

Authors:  Sharon Amir; Ruoxiang Wang; Haim Matzkin; Jonathan W Simons; Nicola J Mabjeesh
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 4.  Aneuploidy and malignancy: an unsolved equation.

Authors:  P Dey
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

5.  High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.

Authors:  Maria E Gonzalez; Esther A Peterson; Lisa M Privette; Janice L Loffreda-Wren; Linda M Kalikin; Elizabeth M Petty
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.

Authors:  E M Rubin; P B DeRose; C Cohen
Journal:  Mod Pathol       Date:  1994-08       Impact factor: 7.842

7.  SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.

Authors:  Sharon Amir; Nicola J Mabjeesh
Journal:  Cancer Biol Ther       Date:  2007-09-01       Impact factor: 4.742

Review 8.  Genomic instability and cancer.

Authors:  George S Charames; Bharati Bapat
Journal:  Curr Mol Med       Date:  2003-11       Impact factor: 2.222

9.  Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization.

Authors:  Mei Zhu; Fengsong Wang; Feng Yan; Phil Y Yao; Jian Du; Xinjiao Gao; Xiwei Wang; Quan Wu; Tarsha Ward; Jingjing Li; Steve Kioko; Renming Hu; Wei Xie; Xia Ding; Xuebiao Yao
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

10.  [Prostate cancers and potential precancerous conditions: DNA cytometric investigations and interphase cytogenetics].

Authors:  G Baretton; T Vogt; C Valina; K Schneiderbanger; U Löhrs
Journal:  Verh Dtsch Ges Pathol       Date:  1993
View more
  6 in total

1.  Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.

Authors:  Laura Stanbery; Elizabeth M Petty
Journal:  Breast Cancer Res       Date:  2012-01-09       Impact factor: 6.466

2.  Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.

Authors:  Mai-Britt W Ørntoft; Hans J Nielsen; Torben F Ørntoft; Claus L Andersen
Journal:  BMC Cancer       Date:  2015-10-29       Impact factor: 4.430

Review 3.  Septin Mutations in Human Cancers.

Authors:  Dimitrios Angelis; Elias T Spiliotis
Journal:  Front Cell Dev Biol       Date:  2016-11-09

Review 4.  Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection.

Authors:  Yu Wang; Pei-Min Chen; Rong-Bin Liu
Journal:  World J Gastrointest Oncol       Date:  2018-01-15

5.  A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia.

Authors:  Christopher J Forlenza; Yanming Zhang; JinJuan Yao; Ryma Benayed; Peter Steinherz; Kavitha Ramaswamy; Rachel Kessel; Mikhail Roshal; Neerav Shukla
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-12-17

6.  Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer.

Authors:  Chang-Qi Cao; Lin Chang; Qi Wu
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.